Department of Surgical PathologyMedical, Molecular and Critical Area, University of Pisa, Pisa, Italy.
Department of Laboratory MedicineSection of Pathology Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Endocr Relat Cancer. 2017 Oct;24(10):543-553. doi: 10.1530/ERC-17-0167.
Noninvasive encapsulated follicular variants of papillary thyroid carcinomas have been recently reclassified as noninvasive follicular thyroid neoplasms with papillary-like nuclear features (NIFTPs). NIFTPs exhibit a behavior that is very close to that of follicular adenomas but different from the infiltrative and invasive follicular variants of papillary thyroid carcinomas (FVPTCs). The importance of miRNAs to carcinogenesis has been reported in recent years. miRNAs seem to be promising diagnostic and prognostic molecular markers for thyroid cancer, and the combination of miRNA expression and mutational status might improve cytological diagnosis. The aim of the present study was to evaluate the miRNA expression profile in wild-type, or -mutated NIFTPs, infiltrative and invasive FVPTCs, and follicular adenomas using the nCounter miRNA Expression assay (NanoString Technologies). To identify the significant Kyoto Encyclopedia of Genes and Genomes (KEGG) molecular pathways associated with deregulated miRNAs, we used the union of pathways option in DNA Intelligent Analysis (DIANA) miRPath software. We have shown that the miRNA expression profiles of wild-type and mutated NIFTPs could be different. The expression profile of wild-type NIFTPs seems comparable to that of follicular adenomas, whereas mutated NIFTPs have an expression profile similar to that of infiltrative and invasive FVPTCs. The upregulation of 4 miRNAs (miR-221-5p, miR-221-3p, miR-222-3p, miR-146b-5p) and the downregulation of 8 miRNAs (miR-181a-3p, miR-28-5p, miR-363-3p, miR-342-3p, miR-1285-5p, miR-152-3p, miR-25-3p, miR-30e-3) in mutated NIFTPs compared to wild-type ones suggest a potential invasive-like phenotype by deregulating the specific pathways involved in cell adhesion and cell migration (Hippo signaling pathway, ECM-receptor interaction, adherens junction, regulation of actin cytoskeleton, fatty acid biosynthesis and metabolism).
最近,非侵袭性包裹滤泡型甲状腺癌已被重新分类为具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤(NIFTP)。NIFTP 的表现非常接近滤泡性腺瘤,但与浸润性和侵袭性滤泡状甲状腺癌(FVPTC)不同。近年来,miRNA 对癌症发生的重要性已被报道。miRNA 似乎是甲状腺癌有前途的诊断和预后分子标志物,miRNA 表达和突变状态的结合可能改善细胞学诊断。本研究旨在使用 nCounter miRNA 表达分析(NanoString Technologies)评估野生型、-突变型 NIFTP、浸润性和侵袭性 FVPTC 和滤泡性腺瘤中的 miRNA 表达谱。为了确定与失调 miRNA 相关的京都基因与基因组百科全书(KEGG)分子途径,我们使用 DNA 智能分析(DIANA)miRPath 软件中的途径联合选项。我们已经表明,野生型和突变型 NIFTP 的 miRNA 表达谱可能不同。野生型 NIFTP 的表达谱似乎与滤泡性腺瘤相似,而突变型 NIFTP 的表达谱与浸润性和侵袭性 FVPTC 相似。4 个 miRNA(miR-221-5p、miR-221-3p、miR-222-3p、miR-146b-5p)的上调和 8 个 miRNA(miR-181a-3p、miR-28-5p、miR-363-3p、miR-342-3p、miR-1285-5p、miR-152-3p、miR-25-3p、miR-30e-3)的下调在突变型 NIFTP 与野生型相比,提示通过调节参与细胞黏附和细胞迁移的特定途径(Hippo 信号通路、ECM-受体相互作用、黏着连接、肌动蛋白细胞骨架调节、脂肪酸生物合成和代谢),具有潜在的侵袭样表型。